High levels of Oct-1 were detected in somatic stem cells and cancer stem cells and correlated with tumor aggressiveness in gastric, prostate, cervical, head and neck cancer, esophageal, colorectal cancers [30–35]. Here, POU2F1 is linked to cancer.